基础医学与临床 ›› 2010, Vol. 30 ›› Issue (1): 80-83.

• 临床园地 • 上一篇    下一篇

222例急性髓系白血病染色体核型与化疗疗效分析

刘蓓 李娟 陈轩 金玉   

  1. 兰州大学第一医院
  • 收稿日期:2009-02-20 修回日期:2009-05-22 出版日期:2010-01-05 发布日期:2010-01-05

Analysis of 222 Cases of Acute Myeloid Leukemia Karyotype and Chemotherapeutic Effect

Bei LIU, Juan LI, Xuan CHEN, Yu JIN   

  1. the First Affiliated Hospital of Lanzhou University
  • Received:2009-02-20 Revised:2009-05-22 Online:2010-01-05 Published:2010-01-05

摘要: 目的 探讨急性髓系白血病染色体核型与化疗疗效关系。方法 用 G显带常规技术对 222例急性髓系白血病患者的核型进行分析。结果 222例中异常核型 86例,占 42.1%;除 M3患者外,其余按 MRC标准分成预后良好、中等和差 3组,给予 TA或 CAG方案化疗,M3 CR率明显高于非 M3;在 TA方案中好核型和中等组 CR率明显优于差组,在 CAG方案中预后中等组 CR率高,良好组与差组 CR率接近,预后差组两方案完全缓解率均低,预后中等组 CAG方案优于 TA方案。结论 染色体核型分析对急性髓系白血病患者化疗疗效及预后判断有指导意义,CAG方案对于原发、初治的老年及低增生性急性髓系白血病患者可作为首选诱导方案。

关键词: 核型分析, 急性髓性白血病, 化疗疗效

Abstract: Objective To explore the relationship of acute myeloid leukemia kayotype with chemotherapeutic effect. Methods Conventional cytogenetic technique of G-band was used to analyze in 222 acute myeloid leukemia patients. Results  Eighty-six cases(42.1%) with cytogenetic abnormalities were found in 204 patients.Excepting for M3 patients ,the favorable,intermediate and adverse groups according for MRC criteria were treated with TA or CAG schema respectively.The CR rate of M3 was obviously higher than non-M3.The favorable and intermediate group were obviously surpassinger than adverse group in TA schema.The CR rate of the intermediate group was highter than that of the other groups in CAG schema.The CR rate of the adverse group in two schema were all low.The CAG was surpassinger than TA schema in intermediate group. Conclusions Cytogenetics is an important chemotherapeutic and prognostic factor to acute myeloid leukemia. CAG schema could be the leader selection in the de novo presby or oligoaccrementional AML patients.

Key words: karyotyping, acute myeloid leukemia, chemotherapeutic effect